武汉永璨生物科技有限公司
+86-17702719238 sales@sun-shinechem.com

MBX-8025 lysine anhydrous

编号: 20542
Cas号: 928821-41-4
纯度: 98% Min.

MBX-8025 lysine anhydrous is a selective PPAR-delta agonist.

仅供研究使用。 我们不向患者出售。

化学信息

名称MBX-8025 lysine anhydrous
Iupac 化学名称Acetic acid, (4-(((2R)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)-, compd. with L-lysine (1:1)
同义词MBX-8025 lysine anhydrous; MBX 8025 lysine anhydrous; MBX8025 lysine anhydrous
英文同义词MBX-8025 lysine anhydrous; MBX 8025 lysine anhydrous; MBX8025 lysine anhydrous
分子式C27H37F3N2O7S
分子量590.65
SmileCCO[C@H](COc1ccc(cc1)C(F)(F)F)CSc2ccc(OCC(=O)O)c(C)c2.NCCCC[C@H](N)C(=O)O
InChiKeyIOIAOZMQFNHRKR-FFHLUDTASA-N
InChiInChI=1S/C21H23F3O5S.C6H14N2O2/c1-3-27-17(11-28-16-6-4-15(5-7-16)21(22,23)24)13-30-18-8-9-19(14(2)10-18)29-12-20(25)26;7-4-2-1-3-5(8)6(9)10/h4-10,17H,3,11-13H2,1-2H3,(H,25,26);5H,1-4,7-8H2,(H,9,10)/t17-;5-/m10/s1
Cas号928821-41-4
相关CAS号

订购信息

包装价格库存纯度备货期
大货询价询价询价
Request Bulk Quote Download MSDS 电话 : +86-177 0271 9238   Email : sales@sun-shinechem.com
外观性状Solid powder
纯度98% Min.
存储Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
可溶性Soluble in DMSO
处理方式
运输条件Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
海关编码
Coming soon.
Targets
Mechanism
Cell study
Animal study
Clinical study

1. Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, Gitlin N, Gordon SC, Odin JA, Sheridan D, Wörns MA, Clark V, Corless L, Hartmann H, Jonas ME, Kremer AE, Mells GF, Buggisch P, Freilich BL, Levy C, Vierling JM, Bernstein DE, Hartleb M, Janczewska E, Rochling F, Shah H, Shiffman ML, Smith JH, Choi YJ, Steinberg A, Varga M, Chera H, Martin R, McWherter CA, Hirschfield GM. Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. Lancet Gastroenterol Hepatol. 2017 Oct;2(10):716-726. doi: 10.1016/S2468-1253(17)30246-7. Epub 2017 Aug 14. PMID: 28818518.

2. Bays HE, Schwartz S, Littlejohn T 3rd, Kerzner B, Krauss RM, Karpf DB, Choi YJ, Wang X, Naim S, Roberts BK. MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin. J Clin Endocrinol Metab. 2011 Sep;96(9):2889-97. doi: 10.1210/jc.2011-1061. Epub 2011 Jul 13. PMID: 21752880.

3. Choi YJ, Roberts BK, Wang X, Geaney JC, Naim S, Wojnoonski K, Karpf DB, Krauss RM. Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia. Atherosclerosis. 2012 Feb;220(2):470-6. doi: 10.1016/j.atherosclerosis.2011.10.029. Epub 2011 Nov 16. PMID: 22169113.

化学结构

20542 - MBX-8025 lysine anhydrous | CAS 928821-41-4

快速订购

Change